Taich Adam — SEC Form 4 filings
SEC reporting owner CIK 1971187. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-09 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 7 filings — 125,867 shares, $5,180,005 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 31,428 shares @ $64.31 ($2,021,125) in 10x Genomics, Inc., filed 2026-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | Chief Financial Officer | 9 | — | 9 legs · 125,867 sh · $5,180,005 | 3 |
| SomaLogic, Inc. (SLGC) | Interim CEO | 1 | — | — | 12 |
Form 4 filings — Taich Adam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 1,206 @ $63.68 · Sale (S): 31,428 @ $64.31 · Sale (S): 13,754 @ $65.26 | EDGAR |
| 2026-08-26 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 17,166 @ $63.02 | EDGAR |
| 2026-05-27 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 15,098 @ $24.44 | EDGAR |
| 2026-03-02 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 106,579 @ $0 | EDGAR |
| 2026-02-25 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 8,968 @ $18.58 | EDGAR |
| 2025-11-25 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 11,888 @ $19.00 | EDGAR |
| 2025-08-26 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 22,315 @ $13.79 | EDGAR |
| 2025-05-27 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 4,044 @ $8.30 | EDGAR |
| 2025-03-19 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 201,704 @ $0 · Grant/award (A): 133,928 @ $0 | EDGAR |
| 2024-01-09 | 4 | SomaLogic, Inc. (SLGC) | Disposition to issuer (D): 48,425 · Disposition to issuer (D): 185,812 (derivative) · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 145,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 95,000 (derivative) · +6 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1971187 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →